13D Filing: Jeffrey Alan Berg and Ntn Buzztime Inc (NYSEMKT:NTN)

Page 1 of 8

You can access the original SEC filing by clicking here.

Ownership Summary Table

Name Sole Voting Power Shared Voting Power Sole Dispositive Power Shared Dispositive Power Aggregate Amount Owned Power Percent of Class
Matador Capital Partners 0 423,000 0 423,000 423,000 17.03%
BFK Investments 0 423,000 0 423,000 423,000 17.03%
Jeffrey A. Berg 10,600 10,600 423,000 433,600 17.46%

Page 1 of 8 – SEC Filing

 

UNITED
STATES

SECURITIES
AND EXCHANGE COMMISSION

Washington,
D.C. 20549

 

SCHEDULE
13D

 

Under
the Securities Exchange Act of 1934

(Amendment
No. 9)

 

NTN
Buzztime, Inc.

(Name
of Issuer)

 

Common
Stock, par value $.005 per share

(Title
of Class of Securities)

 

629410606

(CUSIP
Number)

 

Jeffrey
A. Berg

603
N. Indian River Drive

Suite
300

Ft.
Pierce, FL 34950

(760)
438-7400

(Name,
Address and Telephone Number of Person

Authorized
to Receive Notices and Communications)

 

March
31, 2017

(Date
of Event Which Requires Filing of this Statement)

 

If
the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule
13D, and is filing this schedule because of sections 240.13d-1(e), 240.13d-1(f) or 140.13d-1(g), check the following box. [  ]

 

Note:
Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See
section 240.13d-7 for other parties to whom copies are to be sent.

 

*
The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to
the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided
in a prior cover page.

 

The
information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section
18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the Notes).

 

Potential
persons who are to respond to the collection of information contained in this form are not required to respond unless the form
displays a currently valid OMB control number.

 

 

 

Follow Eterna Therapeutics Inc. (NYSEMKT:ERNA)

































Page 1 of 8